Harvard cardiologist a key player in Guidant deal
22941
Beverly H. Lorell took a leave from her academic job last year to become chief medical and technology officer for Guidant Corp. The post puts her at the center
41931
HARTFORD, Conn., Jan. 7 -- The former chairman and chief executive of the world's largest insurer initiated a deal that led to five former executives being charged with participating in a scheme to manipulate the company's financial statements, a federal prosecutor said Monday during opening...
717588
Indianapolis-based Guidant Corp., which co-promotes Johnson &amp; Johnson&#39;s Cypher drug-coated heart stent, says the device&#39;s market share has risen by as much as half, helped by Boston Scientific Corp.
517153
Boston Scientific Corp. yesterday revealed details about the experimental drug-coated stent it acquired when it bought Guidant Corp. this year. The device will be called Promus, and the Natick medical device maker expects to start selling it in 2008.
229218
Guidant, the maker of implanted heart devices, settled a fraud suit over its recalled defibrillator for an undisclosed amount.
152957
Professor Garret A FitzGerald, an eminent cardiologists, University of Pennsylvania School of Medicine, says doctors should be cautious about using Vioxx type medicines, especially if the patient is at risk of heart disease.
347492
Everybody's getting into hedge funds, including Bill Galvin. The Massachusetts secretary of state, who also happens to be the state's top securities regulator, clearly had the hedge-fund industry in his sights at the start of this year. He began investigating a so-called hedge-fund hotel run in downtown Boston by brokerage giant UBS AG right away. Now Galvin has filed charges ...
182817
Drug giant Johnson & Johnson agrees to buy Guidant Corp, a key player in the heart technology market, for $25.4bn.
659422
Cardiovascular device maker Guidant  Corp. GDT.N said on Thursday it has resolved problems with  its Champion drug-coated stent and plans to launch the heart  device in Europe in mid-2005.
429216
Drug giant Johnson & Johnson is working on a $24bn purchase of medical device firm Guidant Corp, a key player in the heart technology market.
282709
Eight months after Boston Scientific Corp. won a bidding war for heart-device maker Guidant Corp. , loser Johnson &amp; Johnson hit it with a $5.5 billion lawsuit that alleges the Natick company improperly induced Guidant to violate the terms of its acquisition deal with Johnson &amp; Johnson.
97019
Johnson &amp; Johnson is in advanced negotiations to acquire Guidant, an Indianapolis-based medical device maker, for more than $24 billion, executives close to the talks said Monday.
764344
The anti-industry crusader targets pharmaceuticals.
340033
Johnson & Johnson is in advanced negotiations to acquire Guidant, one of the nation's largest makers of devices to treat heart illnesses, for more than $24 billion.
565121
Johnson & Johnson, the pharmaceutical and health care giant, is near a deal to buy Guidant, one of the nation's largest makers of devices to treat heart and circulatory illnesses.
178534
U.S. pharmaceutical company Bristol-Myers Squibb  has hired three Wall Street banks ahead of a possible offer from France's Sanofi-Aventis , the Financial Times reported on Tuesday.
513274
A look behind the scenes at Harvard's Joint Center for Housing Studies might help explain why the director is so sanguine in the face of a bursting bubble.